AGL (Agilon Health) Tariff Resilience Score: 9/10 (As of Jul. 06, 2026)


AGL Agilon Health Inc AGL
74 GF Score
Price $107.37
GF Value $94.40
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Agilon Health Tariff Resilience Score?

Agilon Health AGL -3.28% 74 Tariff Resilience Score is 9 as of Jul. 06, 2026. GuruFocus rates AGL with a GF Score™ of 74/100 and a GF Value™ of $94.40 (Modestly Overvalued). The stock has 7 warning signs investors should review. Among 672 Healthcare Providers & Services companies, Agilon Health ranks better than 99.85% on this metric.

Agilon Health has the Tariff Resilience Score of 9, which implies that the company might have Highly Resilient.

Agilon Health has Agilon Health Inc operates in the healthcare services sector, with minimal exposure to tariffs. Its business model is service-oriented, reducing vulnerability to trade barriers, and it benefits from healthcare industry exemptions.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Agilon Health might have Highly Resilient.


Agilon Health  (NYSE:AGL) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Agilon Health Tariff Resilience Score Related Terms


AGL vs MD, SEM, SGRY: Tariff Resilience Score Comparison

For the Medical Care Facilities subindustry, Agilon Health's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Agilon Health Tariff Resilience Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Agilon Health's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Agilon Health's Tariff Resilience Score falls into.


AGL
74GF Score
Agilon Health Inc AGL
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 9 mean?
Agilon Health (AGL) has a Tariff Resilience Score of 9 as of Jul. 06, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Agilon Health ranks #1 out of 672 companies in the Healthcare Providers & Services industry, placing it in the top 0.099999999999994%.
Is Agilon Health's Tariff Resilience Score too high?
Agilon Health's current Tariff Resilience Score is 9. Based on the distribution chart, Agilon Health ranks #1 out of 672 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Agilon Health has a GF Score™ of 74/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Agilon Health's Tariff Resilience Score compare to MD and SEM?
According to the Healthcare Providers & Services industry distribution chart, Agilon Health ranks #1 out of 672 companies for Tariff Resilience Score. This places Agilon Health in the top 0% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Healthcare Providers & Services company?
A good Tariff Resilience Score depends on the Healthcare Providers & Services industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. Agilon Health's current Tariff Resilience Score is 9. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Agilon Health stock overvalued right now?
Based on GuruFocus' analysis, Agilon Health (AGL) is currently considered Modestly Overvalued. The stock's GF Value™ is $94.40, compared to a current price of $107.37 — trading 13.7% above its estimated fair value. The current Tariff Resilience Score is 9. Agilon Health's overall GF Score™ is 74/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Agilon Health (AGL), the current Tariff Resilience Score is 9 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Agilon Health (AGL) Overvalued in 2026?

Based on GuruFocus' analysis, Agilon Health stock appears to be overvalued. The current stock price of $107.37 is trading 13.7% above its estimated GF Value™ of $94.40. GuruFocus considers Agilon Health to be Modestly Overvalued.

Key valuation signals for AGL:

  • Tariff Resilience Score: 9
  • GF Value™: $94.40 vs. price of $107.37 (13.7% above fair value)
  • GF Score™: 74/100 with 7 warning signs

No single metric tells the full story. See the AGL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Agilon Health Business Description

Address 440 Polaris Parkway, Suite 550, Westerville, OH, USA, 43082
Agilon Health Inc is a healthcare services company that partners with primary care physicians to support value-based care for senior patients. The company provides a platform that enables physician groups to manage healthcare outcomes and costs through a Medicare-centric, capitated care model and long-term partnerships with community-based physicians.
74GF Score

Get the complete analysis for AGL

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$107.37
Price
$94.40
GF Value